Select a medication above to begin.
Symbravo
meloxicam/ rizatriptan
Black Box Warnings .
content coming soon
Adult Dosing .
Dosage forms: TAB: 20 mg/10 mg
New FDA Approval: January 2025
- [content coming soon]
migraine, acute
- [content coming soon]
- Info: meloxicam's exact mechanism of action unknown; inhibits cyclooxygenase, reducing prostaglandin and thromboxane synthesis; rizatriptan activates serotonin 5-HT1B/1D receptors, producing cranial vasoconstriction and inhibiting pro-inflammatory neuropeptide release
Peds Dosing .
- Dosage forms: --
New FDA Approval: January 2025
- [Peds dosing is not applicable for this drug]